Skip to content

Multicomponent Cognitive Behavioral Therapy(CBT) for Posttraumatic Stress Disorder (PTSD) and Substance Abuse

Multicomponent Cognitive Behavioral Therapy for Posttraumatic Stress Disorder and Substance Abuse: A Pilot Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01029197
Acronym
PTSD/SUD
Enrollment
45
Registered
2009-12-09
Start date
2009-08-31
Completion date
2010-06-30
Last updated
2010-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder, Substance Abuse

Brief summary

Purpose: To conduct a pilot study of a cognitive-behavioral treatment (CBT) for PTSD and substance abuse among persons with serious mental illness (SMI) treated in a community setting. Participants: Participants will be 50 volunteer adult individuals with PTSD and substance use disorders (SUD), and SMI who are receiving services at the Freedom House Recovery Center, served through the Orange Person Chatham (OPC) Area Program. Procedures (methods): Participants will be randomly assigned to one of two conditions: 1) the CBT intervention plus treatment as usual; or, 2) treatment as usual.

Interventions

BEHAVIORALCBT and exposure therapy for PTSD

The CBT intervention will be administered twice weekly in group therapy sessions for 7 weeks, and then twice weekly individual sessions for 4 weeks.

OTHERTreatment as Usual

Participants in the treatment as usual condition will receive their usual services at the community clinic where they receive mental health and substance abuse services

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Must be at least 18 years of age * Currently receiving services at Freedom House * Meet DSM-IV criteria for PTSD * Meet criteria for Substance Use Disorder * Able to understand and provide informed consent

Exclusion criteria

• Psychiatric hospitalization or suicide attempt in the past two months

Design outcomes

Primary

MeasureTime frame
Clinician Administered PTSD Scale3 months

Secondary

MeasureTime frame
Addiction Severity Index3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026